Checkpoint Therapeutics

About:

Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.

Website: http://www.checkpointtx.com

Description:

Checkpoint Therapeutics mainly engages in advancing the development of cancer immunotherapy and targeted oncology treatments. It is dedicated to developing and bringing cancer therapies to market faster and actively pursuing product purchases, in-licensing, and co-development opportunities that align with its areas of expertise. The company provides a streamlined approach that lowers risk and accelerates the development and commercialization of oncology drugs, ensuring more patients, payors, and providers benefit from effective and affordable treatment options.

Total Funding Amount:

$22M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)checkpointtx.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-07-02

IPO Status:

Public

Industries:

© 2025 bioDAO.ai